Veru's (VERU) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Jan 2, 2025 · HC Wainwright reissued a "buy" rating and issued a $3.00 price target on shares of Veru in a report on Thursday. ... Veru (NASDAQ:VERU - Get Free Report) last issued its …

$3.00
OFF

Veru's (VERU) Buy Rating Reaffirmed At HC Wainwright - MarketBeat

2 weeks from now

Jan 2, 2025 · HC Wainwright reissued a "buy" rating and issued a $3.00 price target on shares of Veru in a report on Thursday. ... Veru (NASDAQ:VERU - Get Free Report) last issued its …

marketbeat.com

$3.00
OFF

Wainwright Sustains Buy On VERU Shares On Financial Outcomes

2 weeks from now

Dec 20, 2024 · On Friday, H.C. Wainwright reaffirmed its Buy rating on shares of Veru Inc. (NASDAQ: NASDAQ:VERU), with a price target maintained at $3.00. Currently trading at …

investing.com

$2.00
OFF

H.C. Wainwright Reaffirms Their Buy Rating On Veru (VERU)

2 weeks from now

Aug 14, 2023 · In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Veru (VERU – Research Report), with a price target of $2.00. The company’s shares …

businessinsider.com

$3.00
OFF

Wainwright Sustains Buy On VERU Shares On Financial Outcomes

2 weeks from now

Dec 20, 2024 · On Friday, H.C. Wainwright reaffirmed its Buy rating on shares of Veru Inc. (NASDAQ: NASDAQ: VERU), with a price target maintained at $3.00.Currently trading at …

investing.com

$24.00
OFF

H.C. Wainwright Reaffirms Their Buy Rating On Veru (VERU) - ADVFN

2 weeks from now

H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Veru (VERU - Research Report) today and set a price target of $24.00. The company's shares closed yesterday at $16.96.Chen …

advfn.com

$3.00
OFF

H.C. Wainwright Maintains Target On Veru Stock Post-sale

2 weeks from now

Jan 2, 2025 · On Thursday, H.C. Wainwright reaffirmed their optimistic stance on Veru Inc. (NASDAQ: VERU), maintaining a Buy rating and a price target of $3.00.Currently trading at …

investing.com

$3.00
OFF

H.C. Wainwright Maintains Target On Veru Stock Post-sale

2 weeks from now

Jan 2, 2025 · On Thursday, H.C. Wainwright reaffirmed their optimistic stance on Veru Inc. (NASDAQ: VERU), maintaining a Buy rating and a price target of $3.00.Currently trading at …

investing.com

$0.65
OFF

Veru’s (VERU) “Buy” Rating Reaffirmed At HC Wainwright

2 weeks from now

Dec 22, 2024 · NASDAQ VERU opened at $0.65 on Friday. The firm has a market cap of $95.15 million, a price-to-earnings ratio of -1.35 and a beta of -0.50. Veru has a 12-month low of $0.36 …

etfdailynews.com

$24.00
OFF

H.C. Wainwright Keeps Their Buy Rating On Veru (VERU)

2 weeks from now

Sep 8, 2022 · In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Veru (VERU - Research Report), with a price target of $24.00. The company's shares closed …

advfn.com

$24.00
OFF

H.C. Wainwright Reaffirms Their Buy Rating On Veru (VERU)

2 weeks from now

Aug 23, 2022 · H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Veru (VERU - Research Report) today and set a price target of $24.00. The...

advfn.com

$2.00
OFF

H.C. Wainwright Sticks To Its Buy Rating For Veru (VERU)

2 weeks from now

May 15, 2023 · H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Veru (VERU – Research Report) today and set a price target of $2.00. The compan...

businessinsider.com

$3.00
OFF

H.C. Wainwright Reiterates Buy Rating On Veru, Inc. (VERU)

2 weeks from now

Dec 20, 2024 · H.C. Wainwright analyst Yi Chen reiterated a Buy rating and $3.00 price target on Veru, Inc. (NASDAQ: VERU).The analyst commented: "Earlier this week, Veru reported its …

streetinsider.com

FAQs about Veru's (VERU) Buy Rating Reaffirmed at HC Wainwright - MarketBeat Coupon?

Should you buy Veru (Veru – get free report)?

Veru (NASDAQ:VERU – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a report issued on Friday,Benzinga reports. They presently have a $3.00 price target on the stock. HC Wainwright’s price objective indicates a potential upside of 361.54% from the company’s previous close. ...

Should you buy Veru (Veru) stock?

Veru (NASDAQ:VERU – Get Free Report) ‘s stock had its “buy” rating reaffirmed by analysts at HC Wainwright in a research note issued on Thursday, Benzinga reports. They currently have a $3.00 price target on the stock. HC Wainwright’s price objective points to a potential upside of 361.18% from the stock’s previous close. ...

Who owns Veru Inc?

Institutional investors own 47.16% of the company’s stock. (Get Free Report) Veru Inc, a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). ...

Is Veru a biopharmaceutical company?

Veru Inc, a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. ...

Does Gladstone Institutional Advisory LLC own Veru?

Gladstone Institutional Advisory LLC grew its stake in Veru by 34.2% in the 3rd quarter. Gladstone Institutional Advisory LLC now owns 56,876 shares of the company’s stock valued at $44,000 after buying an additional 14,500 shares during the last quarter. Blair William & Co. IL grew its position in shares of Veru by 6.1% in the second quarter. ...